Stock Price
0.51
Daily Change
0.01 2.00%
Monthly
32.47%
Yearly
460.44%
Q2 Forecast
0.49

Starpharma Holdings reported AUD-4.85M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Medical Developments International AUD 1.78M 3.78M Dec/2024
Mesoblast USD -20.3M 2.51M Dec/2025
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025